Clinical Trial

Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients

Study acronym: BK-CTLs
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is a pilot study using cytotoxic T lymphocytes (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Gamma-capture system will be effective in decreasing specific viral load in patients with BK virus viremia and BK virus-associated symptoms post-allogeneic hematopoietic stem cell transplantation (HSCT), renal transplantation, and chemotherapy.
Trial Details
NCT Number NCT04293042
Lead Sponsor Children's Hospital of Philadelphia
Conditions BK Polyomavirus
Enrollment 20 participants
Start Date 2019-10-07
Primary Completion 2028-01-30 (estimated)
Study Completion 2029-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-05